{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:07:27Z","timestamp":1791176847544,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.vaccine.2012.10.092","type":"journal-article","created":{"date-parts":[[2012,11,6]],"date-time":"2012-11-06T02:46:21Z","timestamp":1352169981000},"page":"109-113","source":"Crossref","is-referenced-by-count":76,"title":["Impact of human papillomavirus (HPV) vaccination on HPV 16\/18-related prevalence in precancerous cervical lesions"],"prefix":"10.1016","volume":"31","author":[{"given":"Suzanne E.","family":"Powell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hariri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Steinau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi M.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy M.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen C.","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M.","family":"Niccolai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Schafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth R.","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri E.","family":"Markowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"August (34)","key":"10.1016\/j.vaccine.2012.10.092_bib0005","first-page":"885","article-title":"National vaccination coverage among adolescents aged 13\u201317 years \u2013 United States, 2006","volume":"56","author":"Centers for Disease Control","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"May (20)","key":"10.1016\/j.vaccine.2012.10.092_bib0010","first-page":"626","article-title":"FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Centers for Disease Control","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"August (7)","key":"10.1016\/j.vaccine.2012.10.092_bib0015","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.298.7.743","article-title":"Effect of human papillomavirus 16\/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial","volume":"298","author":"Hildesheim","year":"2007","journal-title":"JAMA"},{"issue":"May (19)","key":"10.1016\/j.vaccine.2012.10.092_bib0020","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"issue":"May (19)","key":"10.1016\/j.vaccine.2012.10.092_bib0025","first-page":"1915","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","author":"Group FIS","year":"2007","journal-title":"N Engl J Med"},{"issue":"March (RR-2)","key":"10.1016\/j.vaccine.2012.10.092_bib0030","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm Rep"},{"issue":"July (30)","key":"10.1016\/j.vaccine.2012.10.092_bib0035","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1016\/j.vaccine.2010.02.019","article-title":"Post-licensure monitoring of HPV vaccine in the United States","volume":"28","author":"Markowitz","year":"2010","journal-title":"Vaccine"},{"issue":"June (9783)","key":"10.1016\/j.vaccine.2012.10.092_bib0040","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(11)60551-5","article-title":"Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study","volume":"377","author":"Brotherton","year":"2011","journal-title":"Lancet"},{"issue":"June (9783)","key":"10.1016\/j.vaccine.2012.10.092_bib0045","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/S0140-6736(11)60650-8","article-title":"HPV vaccine effect: is the glass half full or half empty?","volume":"377","author":"Saraiya","year":"2011","journal-title":"Lancet"},{"issue":"June","key":"10.1016\/j.vaccine.2012.10.092_bib0050","first-page":"464","article-title":"Progress in immunization information systems \u2013 United States, 2010","volume":"61","author":"Centers for Disease Control","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"September (10)","key":"10.1016\/j.vaccine.2012.10.092_bib0055","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJM198009043031003","article-title":"Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine","volume":"303","author":"Broome","year":"1980","journal-title":"N Engl J Med"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2012.10.092_bib0060","doi-asserted-by":"crossref","first-page":"e28435","DOI":"10.1371\/journal.pone.0028435","article-title":"Using the indirect cohort design to estimate the effectiveness of the seven valent pneumococcal conjugate vaccine in England and Wales","volume":"6","author":"Andrews","year":"2011","journal-title":"PLoS ONE"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.10.092_bib0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10552-011-9877-6","article-title":"The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions","volume":"23","author":"Hariri","year":"2012","journal-title":"Cancer Causes Control"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2012.10.092_bib0070","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/LGT.0b013e3182472947","article-title":"Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction","volume":"16","author":"Gargano","year":"2012","journal-title":"J Low Genit Tract Dis"},{"issue":"July (4)","key":"10.1016\/j.vaccine.2012.10.092_bib0075","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jmoldx.2011.03.007","article-title":"Efficient DNA extraction for HPV genotyping in formalin-fixed, paraffin-embedded tissues","volume":"13","author":"Steinau","year":"2011","journal-title":"J Mol Diagn"},{"issue":"3","key":"10.1016\/j.vaccine.2012.10.092_bib0080","doi-asserted-by":"crossref","first-page":"e34044","DOI":"10.1371\/journal.pone.0034044","article-title":"HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001\u20132006","volume":"7","author":"Hariri","year":"2012","journal-title":"PLoS ONE"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.10.092_bib0085","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/0009922810379907","article-title":"Patient\u2013provider communication and human papillomavirus vaccine acceptance","volume":"50","author":"Rand","year":"2011","journal-title":"Clin Pediatr"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2012.10.092_bib0090","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.amepre.2011.06.032","article-title":"Racial\/ethnic and poverty disparities in human papillomavirus vaccination completion","volume":"41","author":"Niccolai","year":"2011","journal-title":"Am J Prev Med"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2012.10.092_bib0095","doi-asserted-by":"crossref","first-page":"696","DOI":"10.4161\/hv.5.10.9515","article-title":"Evaluation of quadrivalent HPV 6\/11\/16\/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection","volume":"5","author":"Olsson","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2012.10.092_bib0100","doi-asserted-by":"crossref","first-page":"b2569","DOI":"10.1136\/bmj.b2569","article-title":"Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study","volume":"339","author":"Castle","year":"2009","journal-title":"BMJ"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.10.092_bib0105","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/AOG.0b013e3182460d9f","article-title":"Human papillomavirus vaccination history among women with precancerous cervical lesions: disparities and barriers","volume":"119","author":"Mehta","year":"2012","journal-title":"Obstet Gynecol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12015654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12015654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T13:53:43Z","timestamp":1540130023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12015654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0264410X12015654"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.10.092","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}